{"database": "lobbying", "table": "lobbying_activities", "rows": [[2340996, "e6cab4c8-7a1a-4c3e-9d8a-effed312664e", "Q3", "RED+BLUE STRATEGIES", 400693064, "BOSTON MEDICAL CENTER", 2019, "third_quarter", "MMM", "H.R. 3 - Lower Drug Costs Now Act - Issues related to the 340(b) program and keeping drugs affordable for lower income Americans.\n\nS. 1895 - Lower Health Care Costs Act - Issues related to surprise billing and transparency.\n\nIssues related to expanding the GME program to allow for additional slots to train physicians in the fight against addiction. \n\nPolicies related to social determinants of health (SDH) with a focus on food as medicine, the importance of stable housing and the need for caregiving supports to help patients to get well and stay well. \n\n\nSupport for the reauthorization of a strong, stable Medicaid DSH program.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2019-10-13T20:41:54.710000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2340996"], "units": {}, "query_ms": 0.2984100137837231, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}